Danaher (XTER:DAP) YoY EBITDA Growth : -12.23% (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Danaher YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Danaher's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -12.23%.

Danaher's EBITDA per Share for the three months ended in Mar. 2024 was €2.36.

Danaher YoY EBITDA Growth Historical Data

The historical data trend for Danaher's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher YoY EBITDA Growth Chart

Danaher Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

7.84

31.13

41.26

14.84

-23.83

Danaher Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-19.55	-26.27	-26.12	-37.51	-12.23

Danaher YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Danaher's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(9.25	-	12.144)	/	\| 12.144 \|
=	-23.83 %

Danaher's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(2.362	-	2.691)	/	\| 2.691 \|
=	-12.23 %

Danaher YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Danaher's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Danaher (XTER:DAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (XTER:DAP) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

DHR:USA DHR:Mexico 1DHR:Italy DAPd:UK DAP:Germany DAP:Germany DHER34:Brazil DHRC:Austria

Address

2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701

Website

https://www.danaher.com

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Danaher (XTER:DAP) Headlines

No Headlines